Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity
Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley
Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley
View: Text | PDF
Research Article Gastroenterology Neuroscience

Activation of pruritogenic TGR5, MrgprA3, and MrgprC11 on colon-innervating afferents induces visceral hypersensitivity

  • Text
  • PDF
Abstract

Itch induces scratching that removes irritants from the skin, whereas pain initiates withdrawal or avoidance of tissue damage. While pain arises from both the skin and viscera, we investigated whether pruritogenic irritant mechanisms also function within visceral pathways. We show that subsets of colon-innervating sensory neurons in mice express, either individually or in combination, the pruritogenic receptors Tgr5 and the Mas-gene–related GPCRs Mrgpra3 and Mrgprc11. Agonists of these receptors activated subsets of colonic sensory neurons and evoked colonic afferent mechanical hypersensitivity via a TRPA1-dependent mechanism. In vivo intracolonic administration of individual TGR5, MrgprA3, or MrgprC11 agonists induced pronounced visceral hypersensitivity to colorectal distension. Coadministration of these agonists as an “itch cocktail” augmented hypersensitivity to colorectal distension and changed mouse behavior. These irritant mechanisms were maintained and enhanced in a model of chronic visceral hypersensitivity relevant to irritable bowel syndrome. Neurons from human dorsal root ganglia also expressed TGR5, as well as the human ortholog MrgprX1, and showed increased responsiveness to pruritogenic agonists in pathological states. These data support the existence of an irritant-sensing system in the colon that is a visceral representation of the itch pathways found in skin, thereby contributing to sensory disturbances accompanying common intestinal disorders.

Authors

Joel Castro, Andrea M. Harrington, TinaMarie Lieu, Sonia Garcia-Caraballo, Jessica Maddern, Gudrun Schober, Tracey O’Donnell, Luke Grundy, Amanda L. Lumsden, Paul Miller, Andre Ghetti, Martin S. Steinhoff, Daniel P. Poole, Xinzhong Dong, Lin Chang, Nigel W. Bunnett, Stuart M. Brierley

×

Figure 4

Colon-innervating DRG neurons respond to pruritogenic agonists for TGR5, MrgprA3, and MrgprC11.

Options: View larger image (or click on image) Download as PowerPoint
Colon-innervating DRG neurons respond to pruritogenic agonists for TGR5,...
(A) Representative Ca2+ responses to the application of the TRPA1 agonist allyl isothiocyanate (AITC; 100 μM), the TGR5 agonist CCDC (100 μM), and the TRPV1 agonist capsaicin (CAP; 1 μM) in 3 DiI-labeled DRG neurons retrogradely labeled from the mouse colon. Right panels show Fura-2 AM image of all cells within the field of view and the 3 DiI-labeled colon-innervating DRG neurons recorded from the left panel. Scale bar: 20μm. (B–F) Representative traces of Ca2+ responses in DiI-labeled colon-innervating DRG neurons to sequential application of AITC (100 μM), the TGR5 agonists (B) deoxycholic acid (DCA; 100 μM), (C) taurolithocholic acid (TLCA; 100 μM), and (D) CCDC (100 μM), or the (E) MrgprA3 agonist chloroquine (CQ; 10 μM) and the (F) MrgprC11 agonist BAM8-22 (2 μM), followed by capsaicin (1 μM) and KCl (50 mM; not shown). DCA, TLCA, CCDC, CQ, and BAM8-22 all activated subpopulations of colon-innervating DRG neurons with varying functional coexpression with TRPA1 (AITC) and/or TRPV1 (capsaicin). (G) Group data showing the percentage of colon-innervating DRG neurons responding to DCA (61 neurons tested), TLCA (93 neurons tested), CCDC (93 neurons tested), CQ (94 neurons tested), and BAM8-22 (110 neurons tested). Each dot represents data from individual coverslips from a total of 6 mice. Data presented are mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts